SELF-BREATHE: a self-guided online program to reduce chronic breathlessness in adults
Official title: A Multicentre, Randomised Controlled Trial Comparing Usual NHS Care to a Self-guided Internet-based Intervention (SELF-BREATHE) Plus Usual NHS Care to Reduce Breathlessness in Adults Living With Chronic Breathlessness
Run by King's College Hospital NHS Trust · NCT06326957 · Data updated 2026-11-12
This study will test whether SELF-BREATHE, a self-guided internet-based support program, can help adults with chronic breathlessness from lung or heart conditions breathe easier and feel less distressed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 246 (estimated) |
| Sponsor | King's College Hospital NHS Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | July 4, 2024 |
| Main results expected | February 2028 |
| Study ends | July 2028 |
| Registry record updated | June 13, 2025 |
| Trial ID | NCT06326957 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with chronic breathlessness (>3 months) despite treatment, an MRC dyspnea score ≥2, ability to consent, and access to an internet-capable device are ideal candidates.
✕Probably not a fit
Patients with breathlessness of unknown cause, primary chronic hyperventilation syndrome, those currently enrolled in pulmonary or cardiac rehabilitation, or those without internet access are unlikely to benefit from this online program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
SELF-BREATHE delivers a self-guided, internet-based supportive program aimed at adults living with chronic breathlessness from conditions such as COPD, interstitial lung disease, bronchiectasis, asthma, or lung cancer. Eligible participants are adults with breathlessness lasting more than three months, with an MRC dyspnea score of 2 or higher, and access to a computer, tablet, or smartphone. The intervention is provided online and outcomes will focus on breathlessness severity, distress, and related health service use. The trial is run from King's College Hospital NHS Foundation Trust in London and targets patients who can participate remotely via the internet.
Why it matters
Potential benefit: If successful, SELF-BREATHE could offer widely accessible support that reduces breathlessness-related distress and may reduce emergency visits and disability.
How similar studies have gone: Face-to-face pulmonary rehabilitation and some digitally supported rehabilitation programs have improved breathlessness and quality of life, but fully self-guided internet-only interventions for chronic breathlessness remain less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥ 18 years of age * Chronic Breathlessness at rest and / or exertion * Chronic Breathlessness (CB) defined as breathlessness that persists (\>3months) despite pharmacological treatment of the underlying disease including, but not limited to; cancer, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), bronchiectasis, chronic fibrotic lung disease following SARS-CoV2 infection * Medical Research Council (MRC) dyspnea score ≥ 2 (MRC 2= short of breath when hurrying on the level or walking up a slight hill * Availability to a computer, tablet, or smart phone with internet access * Able to provide informed consent. Exclusion Criteria: * Breathlessness of unknown cause * Primary diagnosis of chronic hyperventilation syndrome * Currently participating in a rehabilitation programme e.g.,pulmonary/cardiac rehabilitation (patients that have completed PR \>4-weeks will be eligible).
Where it's running
-
King's College Hospital NHS Foundation Trust
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Charles C Reilly, PhD,MSc,BSc — King's College Hospital NHS Foundation Trust, King's College London
- Study coordinator: Charles C Reilly, PhD,MSc,BSc
- Email: charles.reilly@nhs.net
- Phone: 00442032998062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry of healthy controls for respiratory diseases
This study is collecting health information from healthy volunteers to help researchers better understand respiratory diseases like asthma and COPD by comparing it to data from patients with these conditions.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
Using breath analysis to identify multiple lung diseases
This study is testing if analyzing breath samples can help identify different lung diseases like lung cancer and COPD in a large group of 10,000 people.
-
Improving lung capacity with a breathing device called Lung Master
This study is testing if using a breathing device called Lung Master can help improve lung capacity and breathing in healthy adults aged 19-35 and those 65 and older.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.